Breast mass as the initial presentation of esophageal carcinoma: a case report by Norooz, Mohammad Tayefeh et al.
Case report
Open Access
Breast mass as the initial presentation of esophageal carcinoma:
a case report
Mohammad Tayefeh Norooz
1, Laleh Montaser-Kouhsari
1*,
Hamed Ahmadi
1, Mansour Jamali Zavarei
2 and Parviz Daryaei
1
Addresses:
1Department of Oncology, Cancer Institute, Imam-Khomeini Hospital, Blouvar Keshavarz Street, Tehran University of Medical Sciences,
Tehran, 1136746911, Iran
2Department of Pathology, Cancer Institute, Imam-Khomeini Hospital, Blouvar Keshavarz Street, Tehran University of Medical Sciences,
Tehran, 1136746911, Iran
Email: MTN - mdapple197@yahoo.com; LMK* - llmontaseri@gmail.com; HA - hamd.ahmd@gmail.com; MJZ - jamalim@yahoo.com;
PD - drdaryaei.cancersg@gmail.com
*Corresponding author
Received: 6 April 2009 Accepted: 6 May 2009 Published: 7 July 2009
Cases Journal 2009, 2:7049 doi: 10.4076/1757-1626-2-7049
This article is available from: http://casesjournal.com/casesjournal/article/view/7049
© 2009 Norooz et al; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction: Esophageal cancer is considered as a fatal malignancy. It mostly metastasizes to lung,
liver, and bone while breast metastasis has been rarely reported. This is the fifth report of metastatic
breast cancer from esophageal cancer, which differs from previous reported cases in terms of initial
presentation with metastatic breast mass and no metastatic involvement of other organs.
Case presentation: We present a 35-year-old Caucasian woman who initially complained of a
painful breast mass. Squamous pearls on cytologic evaluation suggested a metastatic lesion. Two
months history of dysphagia was extracted through detailed interview with patient and further
investigation revealed a stage IV esophageal squamous cell carcinoma.
Conclusion: In this case, breast lesion as an unusual presentation of esophageal carcinoma
emphasizes the great role of thorough medical history taking and cytologic study in evaluating an
accidentally detected breast mass. The increasing reports of breast metastasis in patients with
esophageal carcinoma necessitate the careful breast examination in visits after treatment of the
primary tumor.
Introduction
Esophageal carcinoma (EC) is considered as the sixth
lethal malignancy [1]. The most common sites of
metastatic involvement in EC are lung, liver and bone
and it exceptionally metastasizes to the breast. Meta-
static breast lesions are commonly detected in known
cases of extramammary malignancies and usually
manifests while there is a widespread metastasis to
other organs [2]. There are only five reports of breast
metastasis from esophageal squamous cell carcinoma
(SCC) in literature so far. Interestingly, this is the first
case of esophageal SCC, which presented with
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no other organ involvement.
Case presentation
A 35-year-old Caucasian woman from northern Iran
visited the Cancer Institute, Imam Khomeini Hospital in
September 2008, with complaint of a painful lump in her
right breast. She also mentioned an intermittent right
parasternal pain, with spread to the back and a 6 kg
weight loss. On examination, there was a 4 ¥ 4.5 cm firm
mass located just below the nipple, which was tender and
mobile. Axillary and cervical chain lymph nodes were not
palpable. Mammography revealed a single mass with
vague margin in deep lower part of right breast, which
had no microcalcification. Laboratory findings showed
elevated Lactate Dehydrogenase (LDH) and Cancer
Antigen (CA-125) plasma level, 364 U/ml (normal
range 129-241 U/ml) and 186 ng/ml (normal range
<35 ng/ml), respectively. The breast tumor was excised
and histological evaluation revealed the presence of
squamous pearls (Figure 1). Immunostaining was nega-
tive for estrogen and progesterone receptors and Human
Epidermal Growth Factor Receptor-2 (HER-2). Thus, the
diagnosis of metastatic squamous cell carcinoma was
made and the patient was subjected to thorough
evaluation to find out the primary site of the tumor.
During the patient’s interview, we found out a 2-month
history of dysphagia, primarily to solid foods with
subsequent difficulty in liquid intake (grade IV), surpris-
ingly not prominent to the patient. Her past medical and
family history revealed no serious disease or malignancy.
She did not mention any specific dietary habit or history
of tobacco and alcohol use. In physical examination, she
was not obese with body mass index of 21, and there was
no palpable lymph node. Carcinoembryonic Antigen
(CEA) was 18 μg/L (normal < 3 μg/L) and Carbohydrate
Antigen 19-9 (CA19-9) was 180 U/ml (normal < 40 U/ml).
All other laboratory parameters including CA-125 were
within normal range. Barium swallow revealed a
stricture with a marked irregularity in the middle part
of esophagus lower to carina. A mass like lesion was
also reported next to the stricture (Figure 2). Upper
gastro-intestinal endoscopy showed a mass, 8 cm in
diameter, placed 25 cm away from incisor teeth and a
second smaller mass with fragile mucosa just under this
area, which has narrowed the esophageal lumen. Biopsy
specimens from both masses and esophageal wall
revealed SCC. Chest computed tomography (CT) with
contrast showed a stricture and wall thickening in distal
part of the esophagus with dilation of proximal part.
Lung parenchyma seemed clear. Abdomino-pelvic CT
was normal with no sign of liver metastasis. With the
diagnosis of esophageal SCC, transhiatal total esopha-
gectomy was performed. One out of four extracted
lymph nodes had tumor involvement. Histopathological
examination confirmed the diagnosis of invasive malig-
nancy (squamous cell type) in middle and lower parts
of esophagus invaded into the adventitia. No vascular
and perineural invasion was identified. The tumor was
close to deep surgical margin (<40* objective field),
Figure 1. Breast histological sample (haematoxylin-eosin stain
40 x) shows the presence of squamous pearls.
Figure 2. Barium swallow reveals the presence of a stenotic
trait in the middle thoracic esophagus.
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margins were free of tumor, with no evidence of tumor
multicentricity. Therefore, the tumor was classified as
pathologic Stage IV and T3N1M1, based on the TNM
classification of malignant tumors. Thus, radiation with
the total dose of 5000 cGy was introduced for the
duration of 45 days. In addition, chemotherapy regimen
consisted of 5-fluorouracil (1500 mg/m
2 iv daily) plus
cisplatin (45 mg/m
2 iv daily) was administered at the
first and last 3 days of radiation therapy.
Discussion
Esophageal cancer is considered a fatal malignancy, which
rapidly spreads throughout the body. Squamous cell
carcinoma, as a major histological subtype, responsible
for 70 percent of EC cases, predominantly involves the
upper and mid-esophagus [3,4]. Early symptoms of EC
such as transient sticking of foods, retrosternal discomfort
or a burning sensation are nonspecific and subtle but
dysphasia with subsequent weight loss, become apparent
when the disease has been disseminated. In fact, 50-60%
of EC tumors are unresectable at the time of diagnosis.
Distant metastasis occurs in 26 percent of locally advanced
ECs in the first 2 years of initial therapy, which mainly
involves lung, skeletal system and liver. Similarly, in all
four previous cases of EC. with breast invasion, the
primary tumor diagnosis and treatment preceded the
detection of metastatic lesion by a time interval between
2months and 2 years [3-5]. Notably, this is the first case of
metastatic esophageal SCC in which the metastatic lesion
as the presenting manifestation lead to identification of
the primary tumor.
Metastatic breast masses account for only 0.4%-6.6% of all
mammary malignancies. In fact, large amount of fibrous
tissue with a moderately poor blood supply of the breast
makes it an unusual site for metastatic lesions [6].
Metastatic breast masses could originate from any types
of malignancies [7]. They dominantly arise from lym-
phoma, melanomas and rhabdomyosarcoma. Most of
breast metastases are identified in known cases of
extramammary malignancies [8,9]. Thus, the metastatic
lesion of an unknown origin is by far the least possible
diagnosis of an accidentally detected breast mass. How-
ever, breast metastasis could be the initial manifestation of
an invasive tumor with mammary invasion in at least one
quarter of occasions. In such situation, the metastasis may
imitate primary benign or malignant neoplasms of the
breast which could puzzle the physician and contribute in
unnecessary surgical treatments [10].
Metastaticlesionshoweverpresentsomefeaturesthatmake
them distinguishable from primary breast tumors. Most
casesofmammarymetastaseswerereportedinyoungerage
than primary breast cancer cases [6]. High blood flow of
breast in young adults considered as the main culprit.
Metastasis is usually a single, painless, mobile, ipsilateral
andwell-circumscribed tumorsitedintheupperquadrants
of the breast. On mammography, it runs the gamut from
normal to different patterns of primary breast carcinoma.
The most common mammographic characteristics are
single or more well-defined masses with high density
with regular margin and no evidence of microcalcification
or skin thickening. Cytologic features of the breast
metastasis may vary from unusual types such as small cell
carcinoma, melanoma,lymphoma,orsquamous andlarge
cell carcinoma to those unrecognizable from primary
adenocarcinoma of the breast [7].
Painfulness of the mass, atypical location and irregular
margins on mammography made the differentiation with
primary breast neoplasm even more difficult in this case
and if it wasn’t for the squamous pearls on pathology as
well as a thorough medical history, the patient would be
misdiagnosed as having the primary breast cancer.
Patients with metastatic EC have a median survival time
of six months and only 14% of patients will survive after
5 years because of the local or distant recurrence.
Chemotherapeutic treatment provides an overall survival
of 12 months [4,7]. Even after complete resection of
esophageal tumor, as the main treatment modality, the
survival rate increases up to 35 percent, on average.
Prognosis for the breast metastasis is very poor and most
of the patients survive less than one year [7]. Surgical
resection of breast metastasis suffices if metastases in
other sites are not present or being under controlled [4].
Therefore, after excising the breast tumor, we only applied
treatment regimen for primary tumor. To date, our patient
has acceptable health condition 6 months after the
treatment with no complication and no sign of
recurrence.
Conclusion
This is the first case of advanced esophageal SCC, which
presented with metastatic breast lesion, no other organic
involvement and atypical clinical and radiographic fea-
tures of the metastatic lesion. Detailed medical history
taking and cytologic study are of at most importance in
evaluating an accidentally detected breast mass in order to
apply proper treatment. The increasing reports of breast
metastasis in EC patients necessitate the careful breast
examination in this group of patients.
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